(Q42668576)

English

Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study

scientific article published on October 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

amyotrophic lateral sclerosis

0 references

author name string

Hyun Young Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Heejaung Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Ki-Wook Oh

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Seong-Il Oh

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Seong-Ho Koh

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Wonki Baik

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Min Young Noh

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Kyung Suk Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Seung Hyun Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

1 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

2724-2731

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Clinical trials in ALS: a review of the role of clinical and neurophysiological measurements

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Mesenchymal stem cells as trophic mediators

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

The functional deficiency of bone marrow mesenchymal stromal cells in ALS patients is proportional to disease progression rate

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Mesenchymal stem cells for the treatment of neurodegenerative disease.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

In vitro evidence for impaired neuroprotective capacities of adult mesenchymal stem cells derived from a rat model of familial amyotrophic lateral sclerosis (hSOD1(G93A)).

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Delayed administration of VEGF rescues spinal motor neurons from death with a short effective time frame in excitotoxic experimental models in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Intricate interplay between astrocytes and motor neurons in ALS.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Ablation of proliferating cells in the CNS exacerbates motor neuron disease caused by mutant superoxide dismutase

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

The neuroprotective effect of erythropoietin-transduced human mesenchymal stromal cells in an animal model of ischemic stroke

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Functional outcome measures as clinical trial endpoints in ALS.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Bone Marrow-Derived Stromal Cells from Amyotrophic Lateral Sclerosis Patients Have Diminished Stem Cell Capacity

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Excellent inter‐rater, intra‐rater, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Identifiers

10.1002/STEM.1770

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42668576&oldid=1965013760"